Patents Assigned to RELMADA THERAPEUTICS
  • Compositions of (-)-17-(Cyclobutylmethyl) Morphinan-3,14-Diol
    Publication number: 20140200237
    Abstract: The present invention is directed to oral, therapeutically effective modified release pharmaceutical compositions of (?)-17-(cyclobutylmethyl)morphinan-3,14-diol and it pharmaceutically acceptable salts and the use thereof, including delayed onset and extended release dosage forms. The present invention is also directed at modified release dosage forms of oral (?)-17-(cyclobutylmethyl)morphinan-3,14-diol which provide robust efficacy and reduced potential for abuse and misuse.
    Type: Application
    Filed: October 31, 2011
    Publication date: July 17, 2014
    Applicant: RELMADA THERAPEUTICS
    Inventor: Najib Babul